Australian Clinical Research Network | Maroubra

Research site

(Unclaimed)

Location

Level 1/725 Anzac Parade, Maroubra, New South Wales, Australia

Site insights

Top conditions

Top treatments

PF-04965842

Bococizumab

Varenicline

Dexamethasone

Beloranib

PF-07038124

Evolocumab

Ruxolitinib

PF-06700841

PF04965842

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 25 total trials

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

The purpose of Part A of this study is to assess the immune response and safety of a booster dose of investigational COVID-19 mRNA vaccines in health...

Active, not recruiting

SARS-CoV-2

Biological: CV0801 Monovalent

Biological: CV0701 Bivalent High dose

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis (TRuE-AD4)

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...

Enrolling

Atopic Dermatitis

Drug: Ruxolitinib Cream

Drug: Vehicle Cream

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting

Coronary Heart Disease (CHD)

Drug: Evolocumab

Drug: Placebo

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis (JADE EXTEND)

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting

Dermatitis, Atopic

Drug: Abrocitinib 200 mg

Drug: Abrocitinib 100 mg

Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared wi...

Active, not recruiting

Osteoarthritis, Knee

Drug: Pentosan Polysulfate Sodium once weekly

Drug: Pentosan Polysulfate Sodium Fixed Dose